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ER residency of the ceramide 
phosphoethanolamine synthase 
SMSr relies on homotypic 
oligomerization mediated by its 
SAM domain
Birol Cabukusta1, Matthijs Kol1, Laura Kneller1, Angelika Hilderink1, Andreas Bickert2, 
John G. M. Mina1, Sergei Korneev1 & Joost C. M. Holthuis1
SMSr/SAMD8 is an ER-resident ceramide phosphoethanolamine synthase with a critical role in 
controlling ER ceramides and suppressing ceramide-induced apoptosis in cultured cells. SMSr-
mediated ceramide homeostasis relies on the enzyme’s catalytic activity as well as on its N-terminal 
sterile α-motif or SAM domain. Here we report that SMSr-SAM is structurally and functionally 
related to the SAM domain of diacylglycerol kinase DGKδ, a central regulator of lipid signaling at the 
plasma membrane. Native gel electrophoresis indicates that both SAM domains form homotypic 
oligomers. Chemical crosslinking studies show that SMSr self-associates into ER-resident trimers and 
hexamers that resemble the helical oligomers formed by DGKδ-SAM. Residues critical for DGKδ-SAM 
oligomerization are conserved in SMSr-SAM and their substitution causes a dissociation of SMSr 
oligomers as well as a partial redistribution of the enzyme to the Golgi. Conversely, treatment of cells 
with curcumin, a drug disrupting ceramide and Ca2+ homeostasis in the ER, stabilizes SMSr oligomers 
and promotes retention of the enzyme in the ER. Our data provide first demonstration of a multi-pass 
membrane protein that undergoes homotypic oligomerization via its SAM domain and indicate that 
SAM-mediated self-assembly of SMSr is required for efficient retention of the enzyme in the ER.
Many proteins have a modular organization in which distinct protein domains provide different functionalities. 
Sterile α -motif or SAM domains are widespread ~70 residue-long protein modules with essential roles in a broad 
variety of biological processes that include cell signaling, calcium homeostasis, synaptic scaffolding, transcrip-
tional repression and translational control1–3. Although they adopt a similar fold, SAM domains are unusually 
versatile in their functional properties. SAM domains can self-assemble into polymers, form heterotypic com-
plexes with SAM domains of other proteins or bind other protein interaction modules. For instance, the SAM 
domain of the transcriptional activator ETS-1 provides a docking site for the ERK-2 MAP kinase to facilitate 
its phosphorylation4. The SAM domain of the transcriptional repressor TEL, on the other hand, functions as 
a self-association motif that controls gene expression through extensive polymerization5. Isolated TEL-SAM 
domains form a head-to-tail polymer with six SAM monomers per turn. The SAM domain of diacylglycerol 
kinase-δ (DGKδ ) forms a polymer with an architecture similar to that of TEL-SAM6,7. In unstimulated cells, 
DGKδ undergoes SAM-mediated self-assembly into cytosolic oligomers, which prevents its translocation to 
the plasma membrane. Stimulation of cells with epidermal growth factor results in oligomer disassembly and 
recruitment of DGKδ to the plasma membrane where the enzyme controls lipid signaling by altering the balance 
between the second messengers diacylglycerol (DAG) and phosphatidic acid6,8.
Besides their role in building homo- and heteromeric protein complexes, SAM domains have also been 
reported to bind RNA and lipids. Smaug in Drosophila and Vts1p in budding yeast control mRNA translation by 
binding to stem-loop structures in their target mRNAs via a cluster of positively charged residues in their SAM 
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domains9,10. The SAM domain of p73, a homolog of the tumor suppressor p53, binds to membrane phospholipids11  
whereas p63, another p53 homolog, shows interactions with the ganglioside GM112. Because of their unique 
ability to recognize a large variety of binding partners, SAM domains cannot be easily categorized. This makes it 
necessary to analyze each SAM domain individually.
The mammalian proteome harbors two known multi-pass membrane proteins that contain a SAM domain, 
namely sphingomyelin synthase SMS1 and the SMS-related protein SMSr, also known as sterile α -motif 
domain-containing protein SAMD8. SMS1 is a Golgi-resident enzyme responsible for bulk production of sphin-
gomyelin (SM), a major structural component of mammalian cell membranes and one of the end products of 
sphingolipid biosynthesis13,14. SMS1 catalyzes the transfer of phosphocholine from phosphatidylcholine onto cer-
amide in the Golgi lumen, a reaction yielding SM and DAG15,16. Thus, SMS1 occupies a key position in balancing 
the cellular levels of pro-apoptotic factor ceramide and mitogenic factor DAG. SMS1 depletion enhances cer-
amide production and apoptotic cell death after photodamage17, while its contribution to the formation of plasma 
membrane-associated SM is critical for Fas-clustering and Fas-mediated apoptosis18. SMS1 deficiency in mice 
causes moderate neonatal lethality as well as loss of fat tissue mass associated with impaired insulin secretion19,20. 
However, the functional relevance of the enzyme’s N-terminal SAM domain is not known.
Unlike SMS1, SMSr does not function as SM synthase but produces small quantities of the SM analogue 
ceramide phoshoethanolamine (CPE) in the lumen of the ER21,22. SMSr is the best-conserved member of the 
SMS enzyme family with homologs present in organisms such as Drosophila, which does not synthesize SM23. 
While the physiological relevance of SMSr-mediated CPE production in mammals remains to be established22,24, 
acute disruption of SMSr catalytic activity in cultured mammalian cells causes a substantial rise in ER ceramides 
and their mislocalization to mitochondria, triggering a mitochondrial pathway of apoptosis21,25. Interestingly, we 
found that SMSr-catalyzed CPE production, although required, is not sufficient to suppress ceramide-induced 
cell death and that SMSr-mediated ceramide homeostasis is critically dependent on the N-terminal SAM domain 
of the enzyme. Based on these results, we postulated a primary role of SMSr in monitoring ER ceramide levels to 
prevent untimely cell death during sphingolipid biosynthesis25.
To further dissect the mechanism by which SMSr controls ceramide levels in the ER, we here focused on the 
function of the enzyme’s N-terminal SAM domain. Our data disclose a striking structural and functional similar-
ity between the SAM domains of SMSr and DGKδ . We show that SMSr-SAM drives the formation of homotypic 
SMSr trimers and hexamers, which resemble the helical oligomers formed by DGKδ -SAM. Moreover, we provide 
evidence that SAM-mediated self-assembly of SMSr is a critical determinant of the enzyme’s subcellular distribu-
tion, hence analogous to the role of SAM in DGKδ .
Results
SMSr-SAM lacks affinity for lipids. We previously demonstrated that SMSr is a CPE synthase that requires 
its N-terminal SAM domain to control ceramide levels in the ER25. As SAM domains have been reported to bind 
lipids11,26,27 including sphingolipids12, we performed photo-affinity labeling experiments with isolated SMSr-SAM 
produced in E. coli using bifunctional lipid analogues that contain a photo-activatable diazirine and a clickable 
alkyne group (Fig. 1a,b)28. Proteins in direct contact with a bifunctional lipid can be crosslinked by UV irradiation 
of the diazirine group. Next, click chemistry is used to label the alkyne group with a fluorescent reporter, allowing 
visualization of the crosslinked protein-lipid complex by in-gel fluorescence. As shown in Fig. 1c, the recombi-
nant START domain of the ceramide transfer protein CERT could be specifically crosslinked with bifunctional 
ceramide. In contrast, recombinant SMSr-SAM was devoid of any specific lipid binding affinity when subjected 
to photo-crosslinking with bifunctional analogues of ceramide (Cer), CPE, SM, DAG, phosphatidylethanolamine 
(PE) or phosphatidylcholine (PC). This led us to explore alternative functions of SMSr-SAM than lipid binding.
SMSr-SAM is structurally and functionally related to DGKδ-SAM. A BLAST search with 
SMSr-SAM as query yielded the SAM domain of DAG kinase DGKδ as a hit with the lowest Expect (E) value 
(i.e. 3E-05) (Suppl. Table 1; Fig. 2a,b). In addition, phylogenetic analysis revealed that SMSr-SAM is more closely 
related to DGKδ -SAM than to the SAM domain of SMS1 (Fig. 2c). Isolated DGKδ -SAM has been shown to 
self-assemble into helical oligomers through a head-to-tail interaction, with six SAM monomers per turn7 
(Fig. 2d). SAM-mediated oligomerization of DGKδ controls its function as a key regulator of lipid signaling by 
sequestering the enzyme in an inactive cellular location6. Moreover, several key residues involved in DGKδ -SAM 
homo-oligomerization are conserved in SMSr-SAM from human to zebrafish, but do not occur in SMS1-SAM 
(Fig. 2b; residues marked by asterisks). This suggested that SMSr-SAM and DGKδ -SAM share a similar function.
To investigate whether SMSr-SAM, like DGKδ -SAM, is able to self-associate into oligomers, we used a method 
originally developed by Knight et al.29. To this end, SMSr-SAM and DGKδ -SAM were expressed in bacteria as 
fusions to a super-negatively charged GFP (scGFP) and run on a native gel (Fig. 2e). The negative charge on GFP 
minimizes the chance of GFP-mediated self-assembly and ensures that all proteins migrate to the cathode while 
the green fluorescence can be used to monitor the migration of the fusion proteins in the native gel. As shown 
in Fig. 2f, polymeric scGFP-DGKδ -SAM displayed a major shift in migration relative to its monomeric control, 
scGFP-DGKδ -SAMV52E. In comparison to scGFP-DGKδ -SAM, scGFP-SMSr-SAM migrated even slower through 
the gel while a significant portion of the protein remained in the gel well (data not shown). These results are 
consistent with those reported by Knight et al.29 and suggested that scGFP-SMSr-SAM forms stable oligomers. 
To verify that oligomerization is mediated by the SAM domain, we mutated each of three conserved residues 
that were previously shown to be critical for homo-oligomerization of DGKδ -SAM, yielding SMSr-SAML62E, 
SMSr-SAMG63D and SMSr-SAMK66E (Fig. 2b). All three mutants migrated faster through the gel than wild-type 
SMSr-SAM (Fig. 2g), indicative of a defect in homo-oligomerization. From this we conclude that SMSr-SAM is 
able to form homo-oligomers.
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SMSr forms SAM-dependent oligomers in the ER. To investigate whether SMSr forms 
homo-oligomers in cells, we performed co-immunoprecipitation (IP) experiments on HeLa cells co-expressing 
V5- and HA-tagged versions of the enzyme. Immunoblot analysis of anti-V5 immunoprecipitates revealed, 
besides monomeric SMSr, also higher-order enzyme complexes that were resistant to SDS under non-reducing 
conditions (Fig. 3a). The migration profiles of the SDS-resistant enzyme complexes and their cross-reactivity 
with both anti-V5 and anti-HA antibodies suggested that they correspond to SMSr trimers and hexamers (see 
also below). When immunoprecipitations were performed on HeLa cells co-expressing full-length SMSr-HA 
and a truncated version of SMSr-V5 lacking the N-terminal SAM-domain, the anti-V5 immunoprecipitates were 
devoid of SMSr-HA and only contained SMSrΔ SAM monomers and dimers (Fig. 3a). Thus, the ability of SMSr 
to form trimers and hexamers appeared critically dependent on its SAM domain. We previously reported that 
removal of its SAM domain causes SMSr to redistribute from the ER to the Golgi25 (see also below). To address 
the possibility that immunoprecipitation of SMSrΔ SAM-V5 fails to bring down SMSr-HA because both proteins 
reside in different organelles, SMSrΔ SAM-V5 was retained in the ER by adding a KKXX ER-retrieval motif to its 
C-terminus. As shown in Fig. 3a, anti-SMSrΔ SAM-V5-KKSA immunoprecipitates were still devoid of SMSr-HA. 
In contrast, co-immunoprecipitation analysis on cells co-expressing full-length and SAM-truncated versions of 
SMS1 revealed that this enzyme self-associates independently of its SAM domain (Fig. 3b). Thus, consistent with 
its ability to self-associate in vitro, SMSr-SAM appears to drive homo-oligomerization of SMSr in the ER.
We noticed that under non-reducing conditions, SMSr monomers, trimers and hexamers all migrate as dis-
crete smears in the gel. Treatment of immunoprecipitates with DTT prior to gel electrophoresis dissolved most of 
the trimers and hexamers, and caused the monomer to migrate as a single protein band (Fig. 3c), indicating that 
Figure 1. The SAM domain of SMSr lacks lipid-binding activity. (a) Photoactivatable and clickable analogue 
of ceramide phosphoethanolamine, pacCPE. (b) Schematic outline of lipid photoaffinity labeling assay. 
Recombinantly produced SAM domains are incubated with liposomes containing bifunctional lipid analogues 
and subjected to UV irradiation. Click chemistry is used to label the alkyne group in the bifunctional lipid with 
N3-AlexaFluor647, allowing visualization of UV-crosslinked protein–lipid complexes by in-gel fluorescence. 
(c) Recombinant GFP-fusions of the SAM domains of SMSr and diacylglycerol kinase DGKδ were subjected 
to lipid photoaffinity labeling using bifunctional analogues of ceramide (pacCer), diacylglycerol (pacDAG), 
CPE (pacCPE), phosphoethanolamine (pacPE), sphingomyelin (pacSM) and phosphatidylcholine (pacPC), 
processed for SDS-PAGE and analyzed by in-gel fluorescence (right) then stained with Coomassie (left). The 
ceramide-binding domain of ceramide transfer protein CERT (CERT-START) and a corresponding ceramide-
binding mutant (CERT-STARTN504A) served as controls.
www.nature.com/scientificreports/
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Figure 2. SMSr-SAM forms homo-oligomers in vitro. (a) Domain representations of SMSr, SMS1 and 
diacylglycerol kinase DGKδ . SMSr and SMS1 have six predicted membrane spans, an active site facing the exoplasmic 
leaflet and an N-terminal SAM domain exposed to the cytosol. DGKδ is a cytosolic protein with an N-terminal 
pleckstrin homology (PH) domain and a C-terminal SAM domain. (b) Sequence alignment of human DGKδ 
-SAM (Uniprot: Q16760), SMSr-SAM (Q96LT4) and SMS1-SAM (Q86VZ5). Note that residues critical for homo-
oligomerization of DGKδ -SAM (marked with an asterisk) are largely conserved in SMSr-SAM  
but not in SMS1-SAM. (c) Phylogenetic analysis of SAM domains of vertebrate homologs of DGKδ , SMSr and SMS1. 
Sequences were aligned using the Clustal Omega multiple sequence alignment tool55 and the phylogenetic tree was 
drawn using ClustalW2 Phylogeny. Database accession numbers used are provided in Supplementary Table 2.  
(d) Space-filling model of the DGKδ -SAM polymer (adapted with permission from Knight M.J. et al. Biochemistry 
2010, 49:9667-9676, copyright 2010, American Chemical Society). (e) Schematic outline of a native gel assay to screen 
SAM domains for their ability to form homo-oligomers. Lysates of bacteria expressing SAM domains fused to super-
negatively charged GFP (scGFP) are run on a native gel and analyzed by in-gel fluorescence. The strong negative 
charge of scGFP helps solubilize SAM domains and drive their migration to the anode. (f) Bacterial lysates containing 
scGFP fusions of DGKδ -SAM, oligomerization mutant DGKδ -SAMV52E or SMSr-SAM were run on a native gel and 
analyzed by in-gel fluorescence. Note that SMSr-SAM, analogous to DGKδ -SAM but contrary to DGKδ -SAMV52E, 
displays a retarded migration indicative of protein oligomers. (g) Bacterial lysates containing scGFP fusions of SMSr-
SAM, SMSr-SAML62E, SMSr-SAMG63D or SMSr-SAMK66E were run on a native gel and analyzed by in-gel fluorescence. 
Note that all SMSr-SAM point mutants display a dramatic shift in gel migration compared to wild-type SMSr-SAM, 
indicative of a perturbation in protein oligomerization.
www.nature.com/scientificreports/
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Figure 3. SMSr forms SAM-dependent homo-oligomers in the ER. (a) Detergent extracts of HeLa cells 
co-transfected with HA-tagged SMSr and V5/His6-tagged SMSr, SMSr∆ SAM, SMSr-KKSA or SMSr∆ SAM-
KKSA were subjected to immunoprecipitation analysis using an anti-V5 antibody. Immunoprecipitates (IP) 
and total extracts (input) were immunoblotted (IB) using anti-V5 and anti-HA antibodies. An asterisk denotes 
immunoreactivity with IgG heavy chain. (b) Detergent extracts of HeLa cells co-transfected with HA-tagged 
SMS1 and V5/His6-tagged SMS1 or SMS1∆ SAM were subjected to immunoprecipitation analysis using an 
anti-V5 antibody. Immunoprecipitates (IP) and total extracts (input) were immunoblotted (IB) using anti-V5 
and anti-HA antibodies, as in (a). (c) HeLa cells transfected with empty vector (EV) or V5/His6-tagged 
SMSr were solubilized using detergent in the presence or absence of 10 mM N-ethyl maleimide (NEM) and 
subjected to Ni2+ -NTA affinity chromatography. Ni2+-NTA eluates were incubated in the presence or absence 
of 100 mM DTT, and immunoblotted (IB) using an anti-V5 antibody, as in (a). (d) HeLa cells transfected with 
HA-tagged SMSr were treated with chemical crosslinker DSP (0–50 μ M, 15 min, RT), solubilized by detergent 
in the presence of 10 mM NEM and subjected to immunoprecipitation analysis using an anti-HA antibody. 
Immunoprecipitates were immunoblotted using an anti-HA antibody. (e) Yeast cells transfected with empty 
vector (EV) or V5/His6-tagged SMSr were treated with DSP as in (d), lysed and subjected to immunoblot 
analysis using an anti-V5 antibody. (f) HeLa cells transfected with empty vector (EV), V5/His6-tagged SMSr or 
SMSr∆ SAM were incubated in the presence or absence of DSP (50 μ M, 15 min, RT), solubilized with detergent 
in the presence of 10 mM NEM and subjected to Ni2+-NTA affinity chromatography. Ni2+-NTA eluates were 
immunoblotted using an anti-V5 antibody. Uncropped images of blots are provided in Supplementary Fig. S1.
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the electrophoretic mobility of SMSr is strongly influenced by the presence of both intermolecular and intramo-
lecular disulfide bonds. To investigate whether these disulfide bonds form before or after cell lysis, cells were lysed 
in the presence of N-ethylmaleimide (NEM), a membrane permeable agent that reacts with free thiol groups. 
NEM treatment recapitulated the effect of DTT addition (Fig. 3c), indicating that the intermolecular and intra-
molecular disulfide bonds in SMSr form after cell lysis, presumably due to the oxidative milieu provided by the 
lysis buffer. Henceforth, NEM was included in the lysis buffer in all subsequent experiments. To verify that SMSr 
also forms trimers and hexamers in intact cells, HeLa cells expressing SMSr-HA were treated with the membrane 
permeable and amine-reactive crosslinker DSP prior to immunopreciptation analysis. As shown in Fig. 3d, DSP 
treatment led to the appearance of SMSr trimers and hexamers in anti-HA immunoprecipitates. These trim-
ers and hexamers became more abundant at the expense of monomers when increasing amounts of crosslinker 
were used. SMSr trimers and hexamers could also be recovered from immunoprecipitates of DSP-treated and 
SMSr-V5-expressing Saccharomyces cerevisiae, an organism lacking endogenous SMSr homologs. Interestingly, 
some trimers and hexamers were also observed when crosslinker was omitted (Fig. 3e). In contrast, immunopre-
cipitates prepared from DSP-treated HeLa cells expressing SMSrΔ SAM-V5 contained monomers and dimers but 
were devoid of any trimers or hexamers (Fig. 3f). From this we conclude that SMSr-SAM mediates self-assembly 
of SMSr into trimers and hexamers in the ER. SMSr lacking its N-terminal SAM-domain, on the other hand, 
appears to retain the ability to form dimers.
Isolation and functional analysis of oligomerization-defective SMSr mutants. To study the func-
tional relevance of SMSr oligomerization in HeLa cells, we first generated an oligomerization-defective SMSr 
mutant. IP analysis of V5-tagged SMSr mutants carrying one of three single residue substitutions that blocked 
SMSr-SAM oligomerization in vitro (Fig. 2g) revealed that each of these reduced the ability of the enzyme to 
self-associate into trimers and hexamers (Fig. 4a). When all three single residue substitutions were combined, we 
observed a substantial reduction in the self-associating properties of SMSr as judged by co-IP analysis (Fig. 4b). 
We named this oligomerization-defective triple mutant SMSrOD. To allow a detailed functional analysis of SMSrOD 
without interference from any endogenous pool of oligomerization-competent SMSr, we created HeLa SMSr 
knockout (SMSr−/−) cells using CRISPR/Cas9 technology. Contrary to wild-type cells, SMSr−/− cells lack a 39-kDa 
protein that cross-reacts with a well-characterized anti-SMSr antibody22 (Fig. 4c). Moreover, SMSr−/− cells were 
virtually devoid of CPE synthase activity (Fig. 4d,e). This is consistent with previous RNAi experiments indicating 
that SMSr is the principal CPE synthase in HeLa cells21. The residual CPE synthase activity detected in SMSr−/− 
cells is likely due to SMS2, which serves as a bifunctional enzyme with both SM and CPE synthase activity30. 
Unlike HeLa cells treated with SMSr-targeting siRNAs, SMSr−/− cells lack any signs of apoptosis (our unpublished 
data). Whether this is due to a compensatory mechanism that overcomes a deregulation of ER ceramides over 
time remains to be established. As shown in Fig. 4f, SMSrOD displayed a reduced ability to self-associate into hex-
amers and trimers following its immunoprecipitation from either DSP-treated wild-type or SMSr−/− cells. Besides 
a marked decrease in the recovery of hexamers and trimmers, DSP-crosslinking of SMSrOD led to appearance 
of dimers (Fig. 4f). Dimers were also observed in crosslinking experiments with the SAM-domain truncation 
mutant but not with the wild-type enzyme (Fig. 3f). Together, these results provide complementary evidence 
that SAM-mediated self-assembly is the key mechanism by which SMSr forms trimers and hexamers in the ER.
SMSr oligomerization is dispensable for catalytic activity and vice versa. To address whether 
an impaired capacity to form homo-oligomers influences the catalytic activity of SMSr, we expressed V5-tagged 
SMSr, SMSrOD and a catalytically dead SMSrD348E mutant in Saccharomyces cerevisiae, an organism lacking endog-
enous CPE synthase activity. Next, catalytic activities of the heterologously expressed enzymes were determined 
in cell lysates using a recently established quantitative CPE synthase activity assay31. Whereas the D348E muta-
tion completely abolished SMSr-mediated CPE production, there was no significant difference between the 
catalytic activities of SMSr and SMSrOD, indicating that the oligomeric state of the enzyme does not critically 
influence its catalytic capacity (Fig. 5a,b). We then addressed whether disrupting catalytic activity influences 
the ability of SMSr to form homo-oligomers. Although introduction of the D348E mutation appeared to render 
SMSr less stable when expressed in HeLa cells, co-IP analysis of SMSr−/− cells co-expressing V5- and HA-tagged 
SMSrD348E showed that catalytic activity per se is not a prerequisite for SMSr self-assembly (Fig. 5c). Moreover, 
DSP crosslinking experiments revealed that SMSrD348E displays the same capacity to self-assemble into hexamers 
and trimers as the wild-type enzyme (Fig. 5d). Collectively, these results indicate that the ability of SMSr to form 
homo-oligomers is dispensable for its catalytic activity and vice versa.
Curcumin promotes SMSr oligomerization. As SMSr is a critical regulator of ER ceramides21,25 and 
because ceramides can trigger ER stress by disrupting Ca2+ homeostasis32, we wondered whether an acute 
imbalance in ER ceramide or Ca2+ levels would influence the oligomeric state of the enzyme. Several drugs 
have been reported to acutely alter ceramide and/or Ca2+ levels in the ER. For instance, curcumin stimulates 
de novo ceramide biosynthesis, presumably by directly activating ceramide synthases in the ER33–35. Tamoxifen 
has been reported to increase ceramide levels by blocking glucosylceramide biosynthesis36,37 whereas thapsi-
gargin is known to release Ca2+ from the ER lumen by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase, 
SERCA38. As shown in Fig. 6a, treatment of SMSr-V5-expressing HeLa cells with curcumin led to the appear-
ance of higher-order enzyme complexes in anti-V5 immunoprecipitates that were resistant to SDS-PAGE under 
reducing conditions. No such complexes were observed in immunoprecipitates from control cells or from cells 
treated with tamoxifen or thapsigargin. Curcumin treatment did not trigger formation of higher-order complexes 
of calnexin, an abundant membrane-anchored chaperone of the ER. The curcumin-induced SMSr complexes 
co-migrated, at least in part, with DSP-crosslinked SMSr trimers and hexamers (Fig. 6b), indicating that cur-
cumin promotes the formation of SDS-resistant SMSr homo-oligomers. A distinct SMSr-containing complex of 
www.nature.com/scientificreports/
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approximately 110 kDa was consistently and exclusively found in curcumin-treated cells (marked with an asterisk 
in Fig. 6a,b). As this curcumin-induced complex did not match the migration profiles of SMSr dimers (~85 kDa), 
trimers (~125 kDa) or hexamers (~250 kDa), we anticipate that it represents a heterologous complex comprising 
SMSr and another, yet-to-be identified protein. Identification of this SMSr interaction partner is the subject of 
ongoing investigations.
Curcumin-induced SMSr oligomerization is independent of fluctuations in ER ceramide or cal-
cium levels. As curcumin has been reported to trigger mitochondrial apoptosis33,35,39, we first examined 
whether its ability to promote SMSr homo-oligomerization relies on activation of an apoptotic pathway. A time 
course experiment revealed that curcumin triggers SMSr oligomerization already within one hour (Fig. 6c). 
Moreover, treatment of cells with the pan-caspase inhibitor zVAD-fmk blocked curcumin-induced PARP cleav-
age but did not prevent formation of SDS-resistant SMSr oligomers (Fig. 6d). Together, these results indicate that 
curcumin promotes SMSr homo-oligomerization independently of its apoptogenic activity.
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Figure 4. Functional analysis of oligomerization-defective SMSr mutants. (a) Detergent extracts of HeLa 
cells transfected with V5-tagged SMSr, SMSrL62E, SMSrG63D and SMSrK66E were subjected to immunoprecipitation 
and immunoblotting using an anti-V5 antibody. An asterisk denotes immunoreactivity with IgG heavy chain. 
(b) HeLa cells co-transfected with V5/His6-tagged and HA-tagged SMSr or SMSrL62E/G63D/K66E (SMSrOD) were 
solubilized with detergent in the presence of 10 mM NEM and subjected to immunoprecipitation analysis using an 
anti-V5 antibody. Immunoprecipitates (IP) and total extracts (input) were immunoblotted (IB) using anti-V5 and 
anti-HA antibodies. An asterisk denotes immunoreactivity with IgG heavy chain. (c) Total membranes of wild-
type (WT) and SMSr knockout (SMSr−/−) HeLa cells were subjected to immunoblot analysis using anti-SMSr and 
anti-calnexin antibodies. (d) TLC analysis of reaction products formed when lysates of WT and SMSr−/− HeLa 
cells were incubated with C6-NBD-ceramide (NBD-Cer). Note that lysates of SMSr−/− cells have a substantially 
reduced capacity to synthesize NBD-CPE. (e) Ratio of quantified NBD-Cer-derived reaction products from (c). 
Data shown are the means of two independent experiments. (f) WT and SMSr−/− HeLa cells transfected with 
HA-tagged SMSr or SMSrOD were incubated in the presence or absence of DSP (50 μ M, 15 min, RT), solubilized 
with detergent in the presence of 10 mM NEM and subjected to immunoprecipitation analysis using an anti-HA 
antibody. Immunoprecipitates were immunoblotted using an anti-HA antibody. NT, non-transfected. Uncropped 
images of blots are provided in Supplementary Fig. S2.
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Since curcumin stimulates de novo ceramide biosynthesis, we next investigated whether formation of 
SDS-resistant SMSr oligomers in curcumin-treated cells is due to an accumulation of ceramides in the ER. We 
previously reported that over-expression of the ceramide transfer protein CERT rescues SMSr-depleted cells 
from ceramide-induced apoptosis by stimulating ceramide export from the ER25. As shown in Fig. 6e, CERT 
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Figure 5. SMSr oligomerization is dispensable for catalytic activity and vice versa. (a) TLC analysis of 
reaction products formed when lysates of yeast cells expressing V5/His6-tagged SMSr, enzyme-dead SMSrD348E 
or SMSrOD were incubated with NBD-Cer (top). SMSr expression was verified by immunoblotting using an 
anti-V5 antibody (bottom). EV, empty vector. (b) Specific activities of V5/His6-tagged SMSr, SMSrOD and 
enzyme-dead SMSrD348E in yeast were determined by quantitative immunoblotting and TLC analysis of reaction 
products formed when lysates were incubated with NBD-Cer and expressed as mmol NBD-CPE formed 
per mol SMSr per second. Data shown are the mean ± S.D. of three independent experiments performed in 
duplicate. (c) SMSr−/− HeLa cells co-transfected with V5/His6-tagged and HA-tagged SMSr or SMSrD348E were 
solubilized with detergent in the presence of 10 mM NEM and subjected to immunoprecipitation analysis 
using an anti-V5 antibody. Immunoprecipitates (IP) and total extracts (input) were immunoblotted (IB) using 
anti-V5 and anti-HA antibodies. (d) SMSr−/− HeLa cells were transfected with HA-tagged SMSr or SMSrD348E 
and incubated in the presence or absence of DSP (50 μ M, 15 min, RT), solubilized with detergent in the presence 
of 10 mM NEM and subjected to immunoprecipation analysis using an anti-HA antibody. Immunoprecipitates 
were immunoblotted using an anti-HA antibody. NT, non-transfected. Uncropped images of blots are provided 
in Supplementary Fig. S3.
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Figure 6. Curcumin promotes SMSr oligomerization independently of fluctuations in ER ceramide 
or Ca2+ levels. (a) HeLa cells transfected with empty vector (EV) or V5/His6-tagged SMSr were treated 
with vehicle (mock), curcumin (50 μ M), tamoxifen (20 μ M) or thapsigargin (2 μ M) for 6 h, solubilized with 
detergent in the presence of 10 mM NEM and subjected to immunoprecipation analysis using anti-V5 antibody. 
Immunoprecipitates (top) or total extracts (middle, bottom) were immunoblotted using anti-V5 (top), anti-
calnexin (middle) and anti-actin antibodies (bottom). (b) HeLa cells transfected with V5/His6-tagged SMSr 
were treated with curcumin (50 μ M, 6 h) or DSP (50 μ M, 15 min) and subjected to immunoprecipation and 
immunoblot analysis using anti-V5 antibody. (c) HeLa cells transfected with empty vector (EV) or V5/His6-
tagged SMSr were treated with 50 μ M curcumin for the indicated time and analyzed as in (b). (d) HeLa cells 
transfected with empty vector (EV) or V5/His6-tagged SMSr were treated with 50 μ M curcumin in the presence 
or absence of 20 μ M of pan-caspase inhibitor zVAD-fmk for 6 h and then subjected to immunoprecipation 
analysis using anti-V5 antibody. Immunoprecipitates and total extracts were immunoblotted using anti-V5 
(top) and anti-PARP1 antibodies (bottom), respectively. FL, full length; CL, cleaved. (e) HeLa cells co-
transfected with V5/His6-tagged SMSr and FLAG-tagged CERT or empty vector (EV) were treated with 50 μ M 
curcumin for 1 h, solubilized with detergent in the presence of 10 mM NEM and subjected to Ni2+-NTA affinity 
chromatography. Ni2+-NTA eluates and total extracts were immunoblotted using anti-V5 (top) and anti-FLAG 
antibodies (bottom), respectively. (f) HeLa cells transfected with empty vector (EV) or V5/His6-tagged SMSr 
were pre-incubated with 1 μ M myriocin, 20 μ M Fuminosin B1 or 2.5 μ M HPA-12 for 5 h and then treated with 
50 μ M curcumin for 1 h, where indicated. Cells were processed as in (e). (g) HeLa cells transfected with empty 
vector (EV) or V5/His6-tagged SMSr were pre-incubated with 100 nM myriocin (1 h) or 50 μ M BAPTA-AM 
(5 min) and then treated with curcumin (50 μ M) or thapsigargin (20 μ M) for 1 h. Cells were processed as in (e). 
A heterologous SMSr-protein complex of ~100 kDa formed in curcumin-treated cells is marked by an asterisk. 
Uncropped images of blots are provided in Supplementary Fig. S4.
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over-expression did not prevent formation of SDS-resistant SMSr oligomers in curcumin-treated cells. We then 
used various well-characterized drugs that block either de novo ceramide biosynthesis or ceramide export from 
the ER. As shown in Fig. 6f, long chain base synthase inhibitor myriocin or ceramide synthase inhibitor fumoni-
sin B1 in each case had no impact on curcumin-induced SMSr oligomerization when added 5 h prior to curcumin 
treatment. Also, addition of HPA-12, a specific inhibitor of CERT-mediated ceramide transport40, did not lead to 
any obvious changes in the oligomeric state of SMSr in either control or curcumin-treated cells (Fig. 6f). From 
this we conclude that curcumin-induced oligomerization of SMSr occurs independently of fluctuations in ER 
ceramide levels.
Besides deregulating ceramide levels in the ER, curcumin promotes the release of Ca2+ from the ER lumen 
by inhibiting SERCA41. BAPTA-AM, a membrane permeable Ca2+ chelator, has been reported to block some 
of the downstream effects of curcumin42,43. However, pre-treatment of cells with BAPTA-AM did not prevent 
curcumin-induced SMSr oligomerization (Fig. 6g). Moreover, addition of thapsigargin, a specific inhibitor of 
SERCA, did not mimic the effect of curcumin on SMSr oligomerization. This indicates that curcumin-induced 
formation of SDS-resistant SMSr oligomers is unlikely mediated by a perturbed Ca2+ homeostasis in the ER. 
Curcumin has previously been reported to crosslink the cystic fibrosis transmembrane conductance receptor 
into SDS-resistant oligomers44 and to promote dimerization of ceramide synthases34. Thus, the appearance of 
SDS-resistant SMSr oligomers in cells treated with curcumin may be due to the crosslinking activity of this drug.
SMSr oligomerization is critical for ER localization. The subcellular distribution of DGKδ is con-
trolled by its SAM domain, which prevents translocation of the enzyme to the plasma membrane by mediating 
its self-assembly into cytosolic oligomers6. Removal of its N-terminal SAM domain caused SMSr to redistribute 
from the ER to the Golgi complex21 (Fig. 7a). In contrast, removal of the N-terminal SAM domain from SMS1 
did not affect its Golgi residency (Fig. 7b). Swapping the entire N-terminal cytoplasmic tail of SMS1 against that 
of SMSr, on the other hand, caused the protein to be retained in the ER21. To investigate whether SAM-mediated 
homo-oligomerization of SMSr plays a role in retaining the enzyme in the ER, we created chimeric SMS1 proteins 
in which the SAM domain is swapped for SMSr-derived wild-type or oligomerization-defective SAM. We named 
these chimeric proteins SAMr-SMS1 and SAMrOD-SMS1, respectively. As shown in Fig. 7b, both SAMr-SMS1 and 
SAMrOD-SMS1 exclusively localized to the Golgi complex. Collectively, these results indicated that SMSr-SAM 
does not mediate ER retention or, alternatively, that such an activity is obscured by the presence of an ER export 
signal in the N-terminal cytoplasmic tail of SMS1 located downstream of its SAM domain. The latter scenario is 
supported by our finding that addition of a C-terminal KKXX ER-retrieval sequence caused a redistribution of 
SMSrΔ SAM from the Golgi to the ER, but failed to retain SMS1 in the ER (Fig. 7a,b).
As alternative approach to investigate whether SAM-mediated oligomerization is part of the mechanism by 
which SMSr is retained in the ER, we next analyzed the subcellular distribution of GFP-tagged SMSr, SMSr∆ SAM 
and SMSrOD in HeLa SMSr−/− cells using confocal fluorescence microscopy. As shown in Fig. 8a, GFP-SMSr 
primarily resides in the ER while a minor but significant pool of the enzyme is localized in the Golgi complex. 
Indeed, intensity plots along a line that crosssections the Golgi complex demonstrated partially overlapping 
intensity peaks for GFP-SMSr and the Golgi marker GM130; such overlap was not observed between intensity 
plots for GM130 and the ER marker calnexin (Fig. 8b). In contrast to GFP-SMSr and in line with our previous 
findings, the bulk of GFP-SMSr∆ SAM localized to the Golgi complex with residual amounts remaining in the 
ER. GFP-SMSrOD, on the other hand, displayed a subcellular distribution intermediate to that of GFP-SMSr and 
GFP-SMSr∆ SAM, with sizeable portions of the enzyme present in both ER and Golgi (Fig. 8a,b). This became even 
more apparent when we quantified the relative portion of GFP-tagged enzyme that co-localized with the Golgi 
marker GM130 using Manders’ co-efficient45 (Fig. 8c). Thus, mutations that perturb SMSr homo-oligomerization 
promote a redistribution of the enzyme from the ER to the Golgi complex. Interestingly, we found that treatment 
of cells with curcumin caused the opposite trend by promoting a redistribution of the enzyme from the Golgi 
to the ER (Fig. 8d). Together, these results indicate that SAM-mediated homo-oligomerization of SMSr serves a 
critical role in retaining the enzyme in the ER.
Discussion
Previous work revealed that SMSr, a CPE synthase with potential dual activity as ceramide sensor, requires its 
N-terminal SAM domain to control ER ceramide levels and suppress ceramide-induced mitochondrial apoptosis. 
In the present study, we uncovered a striking structural and functional similarity between SMSr-SAM and the 
SAM domain of the diacylglycerol kinase DGKδ . We show that SMSr-SAM, analogous to DGKδ -SAM, drives 
self-assembly of the enzyme into oligomers and that SAM-mediated oligomerization is a critical determinant of 
the enzyme’s subcellular localization. Thus, our study provides the first example of a polytopic membrane protein 
that undergoes homotypic oligomerization via its SAM domain and indicates that self-association of SMSr is part 
of the mechanism by which the enzyme is retained in the ER.
Complementary lines of evidence indicate that the SAM domain of SMSr mediates self-assembly of the 
enzyme into oligomers. To begin with, SMSr-SAM is structurally and functionally related to the SAM domain 
of DGKδ , an enzyme that forms homotypic oligomers in the cytosol via its SAM domain to control its function 
as regulator of lipid signaling at the plasma membrane8. Residues critical for oligomerization of DGKδ -SAM 
are conserved in SMSr-SAM and substitution of these residues abolishes self-assembly of isolated SMSr-SAM 
in vitro and weakens the formation of SMSr homotypic oligomers in vivo. Moreover, chemical crosslinking stud-
ies indicate that SMSr self-assembles into trimers and hexamers, thus resembling the helical oligomers formed by 
DGKδ -SAM, which comprise six monomers per turn6. SMSr expressed in budding yeast, an organism that lacks 
structural homologs of SMS enzymes, forms higher-order complexes that co-migrate with SMSr trimers and 
hexamers assembled in human cells, in line with the idea that SMSr oligomerization involves self-assembly of the 
enzyme through its SAM domain and does not rely on any auxiliary protein.
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SAM-mediated oligomerization of DGKδ prevents translocation of the enzyme to the plasma membrane, 
where its presence is required to attenuate DAG signaling and initiate PA signaling6,8,46. Substitution of key resi-
dues at the SAM oligomer interface abolishes DGKδ oligomerization and constitutively localizes the enzyme to 
the plasma membrane6. Analogous to the role of DGKδ -SAM, SAM-mediated oligomerization of SMSr influences 
its subcellular localization. While an oligomerization competent form of SMSr predominantly localizes to the ER, 
mutations that destabilize SMSr oligomers cause a partial redistribution of the enzyme to the Golgi. Conversely, 
treatment of cells with curcumin, a drug that stabilizes SMSr homo-oligomers, promotes retention of the enzyme 
in the ER. It should be noted that combining three point mutations that each disrupt self-assembly of SMSr-SAM 
domains in vitro proved insufficient to completely abolish the formation of SMSr trimers and hexamers in vivo. 
This likely explains why removal of the SAM domain results in a more pronounced redistribution of the enzyme 
to the Golgi than introduction of mutations that only partially undermine SMSr homo-oligomerization. Together, 
our data indicate that SAM-mediated oligomerization of SMSr serves a critical role in retaining the enzyme in 
the ER. This is a remarkable finding in view of the fact that oligomerization has been frequently identified as a 
prerequisite for efficient export of membrane proteins from the ER47–51. How oligomerization of SMSr prevents 
the enzyme from entering COPII vesicles that bud from the ER remains to be established. One possibility is that 
SMSr carries an ER-export signal that is masked by its homotypic oligomerization. Alternatively, SMSr oligomers, 
in contrast to monomers, interact with an ER-resident protein to actively retain them in the ER or simply fail to 
enter COPII vesicles because of their size or shape.
Figure 7. Effect of SAM removal or swapping on the subcellular distribution of SMSr and SMS1.  
(a) Confocal sections of HeLa cells transfected with V5/His6-tagged SMSr, SMSr∆ SAM, SAMr-KKSA, 
or SMSr∆ SAM-KKSA. Cells were immunostained using mouse anti-V5 (red), sheep anti-TGN46 (green) 
and rabbit anti-calnexin primary antibodies (blue) followed by Cy3-conjugated donkey anti-mouse, FITC-
conjugated donkey anti-sheep and Cy5-conjugated donkey anti-rabbit secondary antibodies. Bar, 10 μ m.  
(b) Confocal sections of HeLa cells transfected with HA-tagged SMS1, SMS1∆ SAM, SAMr-SMS1, SAMrOD-
SMS1 or SMS1-KKSA. Cells were immunostained using rabbit anti-HA (red), mouse anti- GM130 (green) and 
goat anti-calnexin primary antibodies (blue) followed by Cy3-conjugated donkey anti-rabbit, Cy2-conjugated 
donkey anti-mouse and Cy5-conjugated donkey anti-goat secondary antibodies. Bar, 10 μ m.
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Figure 8. SMSr oligomerization is critical for ER localization. (a) Confocal sections of SMSr−/− HeLa cells 
transfected with GFP-tagged SMSr, SMSr∆ SAM or SMSrOD. Cells were immunostained using mouse anti-GM130 
(magenta) and rabbit anti-calnexin primary antibodies (green) followed by Cy3-conjugated donkey anti-mouse 
and Cy5-conjugated donkey anti-rabbit secondary antibodies. Bar, 10 μ m. (b) Intensity plots along the paths of 
the arrows in (a), showing overlap between GFP or anti-calnexin (green) and anti-GM130 (magenta) channels. 
(c) Manders’ correlation coefficients of fluorescence-intensity-based colocalization of GFP-tagged SMSr, SMSrOD 
or SMSr∆ SAM with the Golgi marker GM130 was calculated from confocal scanning of complete z-stacks of cells 
treated as in (a). (d) Manders’ correlation coefficients of fluorescence-intensity-based colocalization of GFP-tagged 
SMSr or calnexin with the Golgi marker GM130 was calculated from confocal scanning of complete z-stacks of 
control or curcumin-treated cells (50 μ M, 1 h). For each boxplot in (c) and (d), the middle line denotes the median 
and the top and bottom of the box indicate the 75th and 25th percentile. The whiskers denote the maximum and 
minimum values. P-values of unpaired t-test: *P < 0.05, ***P < 0.001, ****P < 0.0001.
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SMSr belongs to the SMS enzyme family, which includes the Golgi-resident SM synthase SMS1. The latter 
enzyme also contains an N-terminal SAM domain and possesses the ability to self-associate. However, 
both SMS1 self-assembly and its localization to the Golgi complex were completely independent of its SAM 
domain. Moreover, the SMS1-SAM domain lacks the basic assembly of interface residues that are critical for 
homo-oligomerization of SMSr-SAM and DGKδ -SAM. Thus, even though SMSr and SMS1 display a substantial 
degree of structural similarity, their SAM domains appear to serve distinct roles. We previously showed that 
swapping the entire N-terminal cytosolic tail of SMS1 for that of SMSr blocked export of the chimera from the 
ER21. In contrast, exchanging only the SAM domain did not prevent the enzyme from reaching the Golgi. We 
anticipate that the activity of SMSr-SAM as ER retention signal in the SMS1 chimera is overruled by an ER-export 
signal present downstream of its SAM domain. In support of this notion, adding a C-terminal KKXX ER-retrieval 
signal failed to retain SMS1 in the ER but readily restored the ER-residency of SMSrΔ SAM.
SMSr is a critical regulator of ER ceramides, at least in a variety of cultured mammalian cell lines21. The sub-
stantial rise in ER ceramides observed upon acute (siRNA-mediated) depletion of SMSr is difficult to account for 
by loss of the rather modest CPE-producing activity of the enzyme21. We recently reported that SMSr-catalyzed 
CPE production, although required, is not sufficient to suppress ceramide accumulation, ruling out metabolic 
conversion of ceramides as the primary mechanism by which SMSr controls ER ceramide levels25. Instead, we 
found that SMSr-mediated control over ER ceramides relies on its SAM domain; while removal of SAM did not 
affect SMSr-catalyzed CPE production, it abolished the ability of the enzyme to suppress ceramide accumula-
tion even when SMSrΔ SAM is retained in the ER25. This implies that SMSr-SAM, besides trapping the enzyme 
in the ER, directly participates in the mechanism by which SMSr controls ER ceramide levels. Application of 
bifunctional lipid analogues in photo-affinity labeling experiments with recombinant SMSr-SAM did not reveal 
any particular affinity of this domain for any of the enzyme’s lipid substrates or products. In addition, chemical 
crosslinking studies showed that catalytic activity of SMSr is dispensable for the ability of the enzyme to form 
homo-oligomers. Attempts to address whether fluctuations in ER ceramide levels influence the oligomeric state 
of SMSr are inconclusive. Our finding that curcumin stabilizes SMSr homo-oligomers most likely reflects a sec-
ondary effect of this compound as chemical crosslinker44 rather than its ability to stimulate de novo ceramide pro-
duction in the ER33,34. Whether ER ceramides have an impact on SMSr oligomerization remains to be established. 
Dynamic changes in the stoichiometry of membrane proteins are hard to resolve by bulk biochemical approaches 
like chemical crosslinking or co-immunoprecipitation analysis. Therefore, our ongoing efforts focus on the appli-
cation of single-molecule fluorescence microscopy as complementary method to monitor SMSr oligomerization 
in intact cells52.
Methods
Reagents. N-ethyl maleimide (NEM), dithiothreitol (DTT) and myriocin were from Sigma-Aldrich, 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phosphoethanol-amine (DOPE) 
and 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphoethanolamine 
(NBD-PE) from Avanti Polar Lipids, and dithiobis(succinimidyl-propionate) (DSP), mouse monoclonal anti-HA 
agarose beads, C6-NBD-ceramide and N3-Alexa-Fluor647 from Thermo Fischer Scientific. Curcumin and thapsi-
gargin were from Enzo Life Sciences, tamoxifen, fuminosin B1 and BAPTA-AM from Cayman, z-VAD-fmk from 
Merck Millipore, and L-arabinose from Carl Roth. Mouse monoclonal anti-V5 agarose beads were from Bethyl 
Laboratories and Ni-NTA agarose from Qiagen.
Antibodies. The following antibodies were used: mouse monoclonal anti-β -actin (cat. no. A1978, 
1:10,000; Sigma-Aldrich), rabbit polyclonal anti-FLAG (cat. no. 2368, 1:1000; Cell Signaling), mouse mon-
oclonal anti-PARP-1 (sc8007, 1:1000; Santa Cruz), rabbit polyclonal anti-calnexin (sc11397, 1:1000; Santa 
Cruz), mouse monoclonal anti-V5 antibody (R960-25, 1:4000; Invitrogen), rat monoclonal anti-HA antibody 
(12158167001, 1:4000; Roche), rabbit polyclonal anti-HA antibody (71-5500, 1:1000 Invitrogen), goat poly-
clonal anti-calnexin (sc-6465, 1:200; Santa Cruz), sheep anti-TGN46 (AHP500, 1:200 AbD Serotec) and mouse 
monoclonal anti-GM130 antibody (610823, 1:200; BD Biosciences). Goat anti-mouse (cat. no. 31430, 1:5,000) 
and goat anti-rabbit IgG conjugated to horseradish peroxidase (31460, 1:5,000) were from Thermo Fischer 
Scientific. The following secondary antibodies were used for indirect immuno-fluorescence: FITC-conjugated 
donkey anti-sheep/goat (STAR88F, 1:200; AbD Serotec), Cy3-conjugated donkey anti-mouse IgG (715-165-150, 
1:200; Jackson ImmunoResearch), Cy5-conjugated donkey anti-rabbit IgG (711-175-152, 1:200; Jackson 
ImmunoResearch), Cy2-conjugated donkey anti-mouse IgG (715-225-150, 1:200; Jackson ImmunoResearch), 
Cy5-conjugated donkey anti-goat IgG (705-175-147, 1:200; Jackson ImmunoResearch), Cy3-conjugated donkey 
anti-rabbit IgG (711-165-152, 1:200; Jackson ImmunoResearch).
DNA constructs. scGFP-DGKδ -SAM, scGFP-DGKδ -SAMV52E, scGFP-SMSr-SAM and scGFP/pBAD bac-
terial expression vectors were kindly provided by James Bowie, University of California, Los Angeles, USA29. 
For mammalian expression of C-terminal V5/His6- or HA-tagged human SMSr and SMS1, the corresponding 
cDNAs were PCR amplified and cloned into pcDNA3.1/V5-His TOPO (Invitrogen) according to the manufac-
turer’s instructions. SAM-deficient truncation mutants SMSr∆ SAM and SMS1∆ SAM were obtained by deleting 
the first 78 and 68 N-terminal residues, respectively. The C-terminal sequence KKSA was added to retrieve V5/
His6-tagged SMSr∆ SAM in the ER. The first 68 N-terminal residues of HA-tagged SMS1 were replaced with the 
first 78 N-terminal residues of SMSr to generate SAMr-SMS1-HA. Mammalian expression vector pSEMS (Covalys 
Biosciences) containing monomeric eGFP (meGFP) is described in Wilmes et al.53. To obtain meGFP-SMSr, a 
cDNA encoding human SMSr was PCR amplified and inserted into pSEMS/meGFP via XhoI and NotI restriction 
sites. To obtain meGFP-SMSrΔ SAM, the first 78 N-terminal amino acid residues of SMSr were removed during 
the PCR reaction. A mammalian expression construct encoding FLAG-tagged CERT was described in Tafesse 
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et al.25 and a yeast expression construct encoding V5-tagged human SMSr-V5 in Kol et al.31. Single amino acid 
substitutions were introduced by site-directed mutagenesis using the megaprimer PCR method54.
Native gel analysis. The scGFP constructs were transformed into E. coli TOP10 cells (Invitrogen) and trans-
formants were inoculated in 100 ml LB medium containing 50 μ g/ml ampicillin and grown to 0.6 OD600 with shaking 
at 37 °C. After addition of 0.2% L-arabinose, the cultures were transferred to 16 °C for 12–16 h, harvested by centrif-
ugation and resuspended in 1 ml of 20 mM Tris pH 7.4, 1 M NaCl, 1 mM TCEP, 5 mM MgCl2, 5 mg/ml lysozyme, 
20 μ g/ml DNase I and protease inhibitor cocktail (1 μ g/ml aprotinin, 1 μ g/ml leupeptin, 1 μ g/ml pepstatin, 5 μ g/ml 
antipain, 157 μ g/ml benzamidine) followed by 3 rounds of freeze-thawing and 3 rounds of sonication. The lysates 
were centrifuged at 20,000 × g for 30 min at 4 °C and the supernatant was used for native gel analysis. To this end, 
37.5 μ l supernatant was mixed with 12.5 μ l 4× DNA/Native sample buffer (Expedeon) and loaded onto an Any kD™ 
Mini-PROTEAN® TGX Stain-Free™ Protein Gel (BIO-RAD) after normalization of samples for total GFP fluores-
cence. The gel was run in 27.3 mM Tris-HCl and 192 mM glycine at 4 °C and visualized using a Typhoon FLA 9500 
Biomolecular Imager (GE Healthcare) with 473 nm excitation laser and BPB1 emission filter (530/30).
Lipid photoaffinity labeling. Synthesis of photoactivatable and clickable lipid (pacLipid) analogues 
is described in Supplementary Information. Liposomes containing specified pacLipids were prepared from a 
defined lipid mixture (DOPC/DOPE/pacLipid, 80/20/1 mol%) in CHCl3/MeOH (9/1, v/v) using a mini-extruder 
(Avanti Polar Lipids). In brief, 10 μ mol of total lipid was dried in a Rotavap and the resulting lipid film was resus-
pended in 1 ml Buffer L (50 mM Tris-HCl, pH-7.4, 50 mM NaCl) by vigorous vortexing and sonication, yielding a 
10 mM lipid suspension. Liposomes with an average diameter of ~100 nm were obtained by sequential extrusion 
of the lipid suspension through 0.4-micron, 0.2-micron and 0.1-micron track-etched polycarbonate membranes 
(Whatman-Nuclepore) and stored under N2 at 4 °C. Bacterially expressed scGFP-SAM fusion proteins (see above) 
were purified using Ni-NTA agarose chromatography according to instructions of the manufacturer, diluted to 
40 μ g/ml in Buffer L and mixed with pacLipid-containing liposomes at 1:1 (vol:vol). Samples were incubated at 
37 °C for 1 h with shaking and then subjected to UV-irradiation using a 1000 W high-pressure mercury lamp 
(Oriel Photomax) equipped with a pyrex glass filter to remove wavelengths below 350 nm at a 30 cm distance 
from the light source. After addition of 10 μ g soybean trypsin inhibitor as carrier protein, samples were subjected 
to CHCl3/MeOH precipitation and the resulting protein pellets were resuspended in PBS/1% SDS for 15 min at 
70 °C. Click-reactions were performed by incubating ~20 μ g of total protein per sample in 25 μ l PBS/1% SDS con-
taining 1 mM Tris(2-carboxyethyl)phosphin (TCEP), 0.1 mM Tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amin) 
(TBTA), 1 mM CuSO4 and 80 μ M N3-AlexaFluor647 for 1 h at 37 °C. Next, 5× Sample Buffer (300 mM Tris, pH 6.8, 
10% (w/v) SDS, 50% (v/v) glycerol, 10% (v/v) β -mercaptoethanol and 0.025% (w/v) bromophenol blue) was 
added and samples were heated to 95 °C for 5 min prior to SDS-PAGE. The gel was fixed in 40% ethanol and 10% 
acetic acid at RT for 1 h, subjected to in-gel fluorescence analysis using a FLA-9500 Biomolecular Imager with 
635 nm excitation laser and LPR emission filter (665LP), and then stained using Coomassie Blue.
Cell transfection, chemical crosslinking and immuno-affinity chromatography. HeLa cells 
(ATCC-CCL2) were cultured in high-glucose DMEM supplemented 10% FBS. Cells were transfected with DNA 
constructs using Effectene (Qiagen) according to instructions of the manufacturer. For crosslinking experiments, 
cells were treated with 50 mM DSP in PBS for 15 min at RT and quenched with 25 mM Tris pH 7.4 for 10 min 
prior to lysis. At 24 h post-transfection, the cells were lysed in Lysis Buffer (1% TritonX-100, 1 mM EDTA pH 8.0, 
150 mM NaCl, 20 mM Tris pH 7.5, 10 mM N-ethyl maleimide and protease inhibitor cocktail). Nuclei were removed 
by centrifugation at 15,000 × g for 10 min at 4 °C and post-nuclear supernatants were incubated with anti-HA, 
anti-V5 or Ni-NTA agarose beads for 3 h at 4 °C. Beads were washed extensively in Lysis Buffer and then in PBS at 
4 °C. Affinity-purified proteins were eluted in 2% SDS at RT and then analysed by SDS-PAGE and immunoblotting. 
Generation of a SMSr-knockout HeLa cell line using CRISPR/Cas9 technology (HeLa SMSr−/−) was performed as 
described in Supplementary Information. SMSr−/− cells were selected by immunoblotting using an affinity-purified 
rabbit polyclonal anti-SMSr antibody22 and CPE synthase activity assay as described in Vacaru et al.21.
Yeast culture and CPE synthase activity assay. Yeast strain IAY11 (MATα ade2-1 trp1-1can 1-1000 
leu2-3 112 his3–11,15 ura3-52 ade3-∆853) was transformed with pYES2.1/SMSr-V5-His TOPO expression 
constructs and grown in synthetic medium containing 2% (w/v) galactose to early mid-logarithmic phase. For 
crosslinking experiments, cells were treated with indicated amounts of DSP in PBS for 15 min and quenched with 
25 mM Tris pH 7.4 for 10 min at RT prior to lysis. Cells were collected by centrifugation and lysed in ice-cold 
Buffer R (15 mM KCl, 5 mM NaCl, 20 mM HEPES/KOH pH 7.2, 10 mM NEM and protease inhibitor cocktail) 
by bead bashing. Nuclei were removed by centrifugation at 700 × g for 10 min at 4 °C. Post-nuclear supernatants 
(PNS) were subjected to quantitative immunoblot analysis or CPE synthase activity assay as in Ternes et al.30. 
Briefly, 40 nmol 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine was dried under a stream of nitrogen. 
200 μ l Buffer R containing 0.002% Triton X-100 was added and sonicated in a water bath for 15 min. A total of 
200 μ l postnuclear supernatant was added and the mixture was incubated on ice for 1 h. The reaction was started 
by adding NBD-Cer from a 2 mM ethanolic stock to a final concentration of 25 μ M. Enzyme reactions were 
incubated at 37 °C for 1 h with constant shaking. The reaction was stopped by adding 1 ml MeOH and 0.5 ml 
CHCl3. Phase separation was induced by adding 0.5 ml CHCl3 and 0.5 ml of 0.45% (w/v) NaCl. The lower phase 
was evaporated under a stream of nitrogen, dissolved in 25 μ l CHCl3:MeOH (2:1) and then spotted on HP-TLC 
plates (Macherey & Nagel) using a CAMAG Linomat 5 TLC sampler. The TLC was developed first in acetone, 
dried, and then in CHCl3:MeOH:25%NH4OH (50:25:6, v-v:v). Fluorescent lipids were visualized using a Typhoon 
FLA 9500 Biomolecular Imager. NBD-labeled SMS reaction products were quantified using known amounts of 
NBD-PE as reference.
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Fluorescence microscopy. HeLa cells were seeded on glass coverslips and transfected with HA- or 
GFP-tagged SMS constructs using Effectene. After 24 h, cells were fixed with 4% (w/v) paraformaldehyde in PBS, 
quenched in 25 mM NH4 and permeabilized using PBS containing 0.1% (w/v) saponin and 0.2% (w/v) BSA. 
Coverslips were immunostained using primary and fluorophore-conjugated secondary antibodies essentially as in 
Vacaru et al.21. Coverslips were mounted using Prolong Gold Antifade Reagent (Molecular Probes). Images were 
captured using a confocal microscope (Olympus LSM FV1000) with two spectral and a single standard detec-
tor, a UPLSAPO 60x/NA 1.35 oil immersion objective (Olympus) and an Olympus laser box with AOTF laser 
combiner. GFP/FITC/Cy2 fluorophores were excited with a 488 nm Argon laser, Cy3 was excited with a 559 nm 
diode laser and Cy5 was excited with a 635 nm diode laser. Excitation light was reflected by a 405/488/559/635 nm 
dichroic mirror. Emitted light was collected using secondary dichroic mirrors SDM-560 and SDM-640 and a 
barrier filter BA 655–755 for GFP/FITC/Cy2, Cy3 and Cy5, respectively. To avoid crosstalk between imaging 
channels, images for different fluorophores were collected sequentially in a descending order of wavelength i.e. 
from long to short. Imaging of entire cells was done by acquisition of z series of 250 nm step size. Quantitation 
of Golgi-associated levels of GFP-tagged SMSr and calnexin was performed using ImageJ software (NIH). First, 
Golgi regions in transfected cells were determined using anti-GM130 immunostaining. Fluorescence intensity 
values from areas without any cells were taken as background values. After background subtraction, the ratio of 
GFP or calnexin signal intensity within the Golgi region (Manders’ coefficient) were determined using the JaCoP 
plugin of ImageJ software.
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